March Biosciences
UEI: TB1TRLB85UY7
Overview
Awardee Type
Parent
Company Description
Transforming Patient Care by Unlocking New Target Spaces March Biosciences is a clinical-stage company in the cell therapy field focused on developing CAR-T cell strategies to address the most challenging hematological cancers Pipeline MB-105 https://march.bio/wp-content/uploads/2023/05/shutterstock_1008023995-HD-30.mp4 Focused on Excellence Target Space Our approach combines biological and engineering insights to enable target-unlock without the risk and complexity
Name
March Biosciences
Website
Headquarters
Houston, TX
United States
United States
Most Recent Award
Sept. 1, 2024
Calculating
Federal grant recipient
MARCH BIOSCIENCES INC
(UEI TB1TRLB85UY7)
is headquartered in Houston TX.
The corporation
was founded in April 2021 and
federally registered in
December 2022.
Federal Award Analysis
March Biosciences federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
MARCH BIOSCIENCES INC
Division Name
MARCH BIOSCIENCES
UEI
TB1TRLB85UY7
Primary NAICS
None Reported
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Assistance Awards
Date Founded
April 21, 2021
Initial Registration
Dec. 22, 2022
Last Registration
Nov. 11, 2024
Registration Activation
Nov. 11, 2024
Registration Expiration
Nov. 7, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Reported NAICS
None Reported
Accepts Credit Cards
No